Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 Assay (kPCR)

Journal of Clinical Virology

Volumn 58, Issue 3, 2013, Pages 522-527

  Kessler, Harald H ^a   Hübner, Margit ^a   Konrad, Petra M ^a   Stelzl, Evelyn ^a   Stübler, Madeleine M ^a   Baser, Merve H ^a   Santner, Brigitte I ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

COBAS TaqMan HCV; Genotype; Quantitation; Real time PCR; Subtype; Versant HCV RNA

Indexed keywords

VIRUS RNA;

AMPLIPREP COBAS TAQMAN HCV QUANTITATIVE TEST VERSION 2.0; ARTICLE; DIAGNOSTIC KIT; GENOTYPE; HEPATITIS C VIRUS; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; VERSANT HEPATITIS C VIRUS RNA 1.0 ASSAY; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS EXAMINATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS TITRATION;

COBAS TAQMAN HCV; GENOTYPE; QUANTITATION; REAL-TIME PCR; SUBTYPE; VERSANT HCV RNA;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84886243342     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.005     Document Type: Article

References (24)

1. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36:S35-S46.
2. European Association of the Study of the Liver EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011, 55:245-264.
3. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. American Association for the Study of Liver Diseases, Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
4. Sarrazin C., Berg T., Ross R.S., Schirmacher P., Wedemeyer H., Neumann U., et al. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterologie 2010, 48:289-351.
5. Chevaliez S., Rodriguez C., Pawlotsky J.M. New virologic tools for management of chronic hepatitis B and C. Gastroenterology 2012, 142:1303-1313.
6. Fried M.W., Hadziyannis S.J., Shiffman M.L., Messinger D., Zeuzem S. Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection. J Hepatol 2011, 55:69-75.
7. Jacobson I.M., McHutchison J.G., Dusheiko G., Di Bisceglie A.M., Reddy K.R., Bzowej N.H., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011, 364:2405-2416.
8. Jacobson I.M., Marcellin P., Zeuzem S., Sulkowski M.S., Esteban R., Poordad F., et al. Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and prginterferon/ribavirin. Hepatology 2012, 56:567-575.
9. Jacobson I.M., Bartels D.J., Gritz L., Kieffer T.L., De Meyer S., Tomaka F., et al. Futility rules in telaprevir combination treatment. J Hepatol 2012, 56(Suppl. 2):S24.
10. Sarrazin C., Hezode C., Zeuzem S., Pawlotsky J.M. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012, 56(Suppl.1):88-100.
11. Sarrazin C., Dragan A., Gärtner B.C., Forman M.S., Traver S., Zeuzem S., Valsamakis A. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS AmpliPrep/COBAS TaqMan) for quantitation of HCV RNA. J Clin Virol 2008, 43:162-168.
12. Vermehren J., Yu M.I., Monto A., Yao J.D., Anderson C., Bertuzis R., et al. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. J Clin Virol 2011, 52:133-137.
13. Saldanha J., Lelie N., Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA, WHO Collaborative Study Group. Vox Sang 1999, 76:149-158.
14. Saldanha J., Heath A., Aerham C., Albrecht J., Gentili G., Gessner M., Pisani G. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang 2005, 88:202-204.
15. Chevaliez S., Bouvier-Alias M., Brillet R., Pawlotsky J.M. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 2007, 46:22-31.
16. Barritt A.S., Fried M.W. Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus. Gastroenterology 2012, 142:1314-1323.
17. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Communities 1998, L331:1-37.
18. Caliendo A.M., Valsamakis A., Zhou Y., Yen-Lieberman B., Andersen J., Young S., et al. Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 2006, 44:1726-1732.
19. Elkady A., Tanaka Y., Kurbanov F., Sugauchi F., Sugiyama M., Khan A., et al. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1-4. J Med Virol 2010, 82:1878-1888.
20. ® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison. J Clin Virol 2011, 50:100-103.
21. LaRue H., Rigali L., Balada-Llasat J.M., Pancholi P. Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes. J Clin Microbiol 2012, 50:1769-1772.
22. Vermehren J., Colucci G., Gohl P., Hamdi N., Abdelaziz A.I., Karey U., et al. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity. J Clin Microbiol 2011, 49:3309-3315.
23. ® HCV Test, v2.0 compared to assays used in routine clinical practice and drug trials. Hepatology 2012, 56:676A-677A.
24. Chevaliez S., Bouvier-Alias M., Rodriguez C., Soulier A., Poveda J.D., Pawlotsky J.M. The Cobas AmpliPrep/Cobas TaqMan HCV Test, version 2.0 Real-time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA. J Clin Microbiol 2013, 51:1078-1082.